Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade
- PMID: 27274368
- PMCID: PMC4891535
- DOI: 10.4097/kjae.2016.69.3.239
Relationship between first-twitch depression and train-of-four ratio during sugammadex reversal of rocuronium-induced neuromuscular blockade
Abstract
Background: The primary outcome of sugammadex reversal for rocuronium-induced neuromuscular block (NMB) is a train-of-four ratio (TOFR) of 0.9, not first twitch (T1) height. We investigated whether the recovery of TOFR or T1 differs based on the reversal of NMB with neostigmine or sugammadex.
Methods: The acceleromyographic responses from 0.6 mg/kg of rocuronium were monitored supramaximally in 80 patients after induction of anesthesia. The TOFR and T1 height were recorded, and saved in a personal computer using TOF-Watch SX Monitor software in all patients. Patients were randomly assigned to 2 groups to receive either neostigmine 50 µg/kg with glycopyrrolate 10 µg/kg (neostigmine group, n = 40) or sugammadex 2.0 mg/kg (sugammadex group, n = 40). The primary objective was to determine the difference of recovery time between TOFR to 0.9 and T1 to 0.9 after sugammadex or neostigmine administration during moderate rocuronium-induced NMB.
Results: The recovery pattern of the TOFR 2 min after sugammadex administration was 1.0 or more, but that of T1 was less than 90% (T1 / control value) up to 6 min after drug was injected. The recovery pattern of TOFR and T1 was similar during the 20 min after reversal with neostigmine.
Conclusions: If you have not performed the T1 monitoring, both TOFR and T1 should be considered to confirm suitable recovery during the 6 min after reversal with sugammadex during rocuronium-induced moderate NMB.
Keywords: Neostigmine; Neuromuscular monitoring; Rocuronium; Sugammadex.
Figures



Similar articles
-
Reversal with sugammadex in the absence of monitoring did not preclude residual neuromuscular block.Anesth Analg. 2013 Aug;117(2):345-51. doi: 10.1213/ANE.0b013e3182999672. Epub 2013 Jun 11. Anesth Analg. 2013. PMID: 23757472
-
Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.Anesth Analg. 2007 Mar;104(3):569-74. doi: 10.1213/01.ane.0000248224.42707.48. Anesth Analg. 2007. PMID: 17312210 Clinical Trial.
-
Recovery of early postoperative muscle strength after deep neuromuscular block by means of ultrasonography with comparison of neostigmine versus sugammadex as reversal drugs: study protocol for a randomised controlled trial.BMJ Open. 2021 Feb 26;11(2):e043935. doi: 10.1136/bmjopen-2020-043935. BMJ Open. 2021. PMID: 33637547 Free PMC article.
-
Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature.BMC Anesthesiol. 2019 Aug 17;19(1):160. doi: 10.1186/s12871-019-0829-0. BMC Anesthesiol. 2019. PMID: 31421671 Free PMC article. Review.
-
The comparative efficacy and safety of sugammadex and neostigmine in reversing neuromuscular blockade in adults. A Cochrane systematic review with meta-analysis and trial sequential analysis.Anaesthesia. 2018 May;73(5):631-641. doi: 10.1111/anae.14160. Epub 2017 Dec 27. Anaesthesia. 2018. PMID: 29280475
Cited by
-
Administration of neostigmine after tracheal intubation shortens time to successful intraoperative neuromonitoring during thyroid surgery: a randomized controlled trial.Sci Rep. 2022 Oct 7;12(1):16797. doi: 10.1038/s41598-022-21282-5. Sci Rep. 2022. PMID: 36207389 Free PMC article. Clinical Trial.
-
Effects of different sugammadex doses on the train of four ratio recovery progression during rocuronium induced neuromuscular blockade in the rat phrenic nerve hemidiaphragm.Korean J Anesthesiol. 2020 Jun;73(3):239-246. doi: 10.4097/kja.19278. Epub 2019 Oct 17. Korean J Anesthesiol. 2020. PMID: 31619027 Free PMC article.
-
Efficacy and safety of sugammadex versus neostigmine in reversing neuromuscular blockade in adults.Cochrane Database Syst Rev. 2017 Aug 14;8(8):CD012763. doi: 10.1002/14651858.CD012763. Cochrane Database Syst Rev. 2017. PMID: 28806470 Free PMC article.
References
-
- Murphy GS, Szokol JW, Marymont JH, Greenberg SB, Avram MJ, Vender JS, et al. Intraoperative acceleromyographic monitoring reduces the risk of residual neuromuscular blockade and adverse respiratory events in the postanesthesia care unit. Anesthesiology. 2008;109:389–398. - PubMed
-
- van Santen G, Fidler V, Houwertjes MC, Top WM, Wierda JM. The effect of single twitch and train-of-four stimulation on twitch forces during stable neuromuscular block. J Clin Monit Comput. 2000;16:529–533. - PubMed
-
- Fuchs-Buder T, Claudius C, Skovgaard LT, Eriksson LI, Mirakhur RK, Viby-Mogensen J. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand. 2007;51:789–808. - PubMed
-
- Suzuki T. A train-of-four ratio of 0.9 may not certify adequate recovery after sugammadex. Acta Anaesthesiol Scand. 2011;55:368–369. - PubMed
-
- Staals LM, Driessen JJ, Van Egmond J, De Boer HD, Klimek M, Flockton EA, et al. Train-of-four ratio recovery often precedes twitch recovery when neuromuscular block is reversed by sugammadex. Acta Anaesthesiol Scand. 2011;55:700–707. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources